Researchers developed a novel multimodal imaging approach to detect frontotemporal degeneration, showing improved diagnostic specificity and accuracy. The method integrates measures of white matter and grey matter, enabling the screening of patients for clinical trials.
A new study reveals that telestroke programs in Oregon increased access to life-saving stroke care by 40%, extending coverage to previously uncovered communities. The program utilizes telemedicine systems to bring expert consultations and treatments, reducing disparities in stroke care access.
A new tau transmission model opens doors for potential treatments of Alzheimer's and Parkinson's diseases by inducing animal models to mimic the spread of tau pathology. The research demonstrates cell-to-cell transmission of neurodegenerative proteins, offering therapeutic opportunities.
A new influenza vaccine approach uses two-pronged immune cell strategy to elicit robust protective immunity. The research suggests that combining CD8+ T cells and non-neutralizing antibodies could provide universal flu vaccine capable of long-lasting protection.
Researchers have discovered that a protein switch called Ebf2 determines the development of brown fat cells, which are thought to counteract obesity by burning excess energy. The study found that Ebf2 regulates the binding activity of PPAR-gamma, a protein that regulates differentiation of developing cell types.
Scientists have identified a molecular mechanism underlying sleep homeostasis in nematode worms, which may have implications for human health. The study found that loss of sleep led to the migration of a stress-related protein into the nucleus, activating stress genes and triggering a behavioral response.
A team of researchers discovered that ATP release is key to transmitting sweet, bitter, and umami taste information to the brain. The CALHM1 channel protein plays a crucial role in releasing ATP, allowing taste buds to send signals to the brain for these three primary taste types.
A Penn Medicine physician highlights the need for a unified approach to value in health care reform, as divergent priorities between patients and physicians create obstacles. Patients and physicians have different notions of value, with patients seeking enhanced experiences and physicians focusing on efficiency and evidence-based care.
A new study confirms the effectiveness of colonoscopy in preventing advanced colorectal cancer diagnoses, particularly for tumors on the right side of the colon. The study found a 70 percent reduction in risk for average-risk adults, supporting current medical recommendations.
Researchers found that DHA, an omega-3 fatty acid found in oily fish, activates ion channels to lower blood pressure. In contrast, the ethyl ester form of DHA, commonly used in fish oil pills, fails to activate these channels and may even counteract their effects.
Researchers have found new candidate disease proteins for neurodegenerative disorders, including two RNA-binding proteins with prion-like segments associated with inherited forms of ALS and multisystem proteinopathy. Mutations in these proteins accelerate the formation of self-organizing fibrils that contribute to disease.
Scientists at the University of Pennsylvania School of Medicine have discovered a way to repair lung damage caused by asthma and chronic obstructive pulmonary disease (COPD) by tweaking gene expression. They found that epigenetic regulators, including HDAC2, play a critical role in regulating lung development and regeneration.
Scientists successfully repurposed human alpha cells into functional beta cells by modifying chromatin material, demonstrating the potential for a novel diabetes treatment. The study also reveals that many genes in alpha cells are marked with both activating and repressing histone modifications.
A new study by researchers at the University of Pennsylvania School of Medicine found that minimally invasive therapies can effectively remove damaged cells from patients with Barrett's esophagus, reducing cancer progression. In over two-thirds of cases, patients had no signs of disease return for years.
A new paradigm for therapeutics discovery is proposed by Garret FitzGerald, MD, FRS, to address the unsustainable model of current drug development in the US. The approach aims to integrate knowledge of preclinical science with an understanding of drug action in humans, leading to improved prediction of efficacy and safety.
The precise determination of genomic information is hindered by a lack of understanding of sequence variations. Interdisciplinary teams are needed to address the substantial uncertainty in interpreting genomic data for better application.
Research on the Florida carpenter ant reveals that epigenetic regulation plays a key role in distinguishing two worker castes with strikingly different behaviors and physical characteristics. Histone modifications, including those influenced by the CBP regulator, are found to correlate with gene expression levels and cognitive abilities.
A team from the University of Pennsylvania School of Medicine has identified a molecular master switch for pancreatic cancer, which could serve as a potential predictor of treatment outcome. The researchers found that Prrx1 and Sox9 regulate the emergence of an intermediate cell type that can give rise to cancer.
A new Penn study found no evidence to support concerns that abnormal disease proteins are infectious and can be transmitted from one person to another. Researchers analyzed data from a cohort of patients who received human growth hormone therapy and found no cases of Alzheimer's, Parkinson's, or other neurodegenerative diseases.
A Penn study found that patients' end-of-life care preferences are heavily influenced by default options, with most preferring comfort-oriented care. The research suggests that clinicians should be aware of this phenomenon when recommending advance directives to their patients.
A team of researchers found that specific acetylation marks on histone H4 determine the balance between two proteins, BRCA1 and 53BP1, controlling DNA repair mechanisms. This balance affects a cell's ability to repair breaks and respond to chemotherapy.
A new study from the University of Pennsylvania School of Medicine reveals high levels of approval among trauma patients, families, and communities to participate in clinical trials without express consent. The findings provide important clues for increasing studies aimed at improving care for time-sensitive injuries.
A two-step personalized immunotherapy treatment using dendritic cell vaccine and adoptive T cell therapy has triggered anti-tumor immune responses in patients with late-stage ovarian cancer. Four of six patients treated responded to the therapy, showing promising early results.
Researchers at Penn have identified innate lymphoid cells as a possible therapeutic target for treating atopic dermatitis, also known as eczema. The study found that these cells contribute to disease progression and may be regulated by different pathways in the skin.
A new study from the University of Pennsylvania found that patient-directed problem-solving approaches improved HIV drug adherence, with patients taking nearly twice as many prescribed doses as those in standard care. This approach also led to a 50% improvement in viral suppression rates.
A new study from the University of Pennsylvania School of Medicine found that gene therapy improves vision in patients with Leber congenital amaurosis, but also advances retinal cell degeneration. The research provides a more nuanced understanding of the disease and its treatment.
A study by University of Pennsylvania researchers found that psychiatrists exposed to COI policies during residency are less likely to prescribe brand-name antidepressants after graduation. The results suggest that COI policies can lower rates of prescribing heavily promoted antidepressants, potentially reducing cost growth.
Researchers identified a host signaling pathway used by malaria parasites to escape host cells, allowing for potential new strategies to combat the disease. A compound called sotrastaurin, already tested in humans and deemed safe, showed promise as an oral antimalarial.
A study analyzing over 25,000 message board posts found that breast cancer survivors frequently discuss troublesome side effects from aromatase inhibitors, leading some to discontinue or switch therapies. The findings have broad implications for promoting proper adherence and informing patient-to-patient discussion online.
Researchers at the University of Pennsylvania School of Medicine developed a new animal model that replicates the transmission of tau pathology, a hallmark of Alzheimer's disease. The study demonstrates that synthetic tau fibrils can induce authentic neurofibrillary tangles and initiate disease progression in mice.
Researchers discovered a class of p53 target genes and regulatory molecules that regulate metabolism and senescence in cells. Malic enzymes, identified as novel pharmaceutical targets for anticancer therapy, may also play a role in the normal process of cellular aging.
Researchers found no link between untreated Parkinson's and impulse control disorders. However, studies suggest that exposure to dopamine-related drugs may increase impulsive behaviors in patients with the disease.
A new study from the University of Pennsylvania School of Medicine found that black and Hispanic patients are less likely to complete substance abuse treatment programs compared to white patients. The study suggests that socioeconomic factors, such as unemployment and housing instability, contribute to these disparities.
A 520-day space simulation revealed alterations in sleep patterns and neurobehavioral consequences for astronauts. The study highlights the need for artificial light exposure, food intake, and exercise to maintain human behavior during prolonged space missions.
A team of researchers at the University of Pennsylvania School of Medicine discovered that metformin suppresses glucagon's ability to generate a signaling molecule, pointing to new drug targets. This finding could lead to improved diabetes treatments with reduced side effects.
A Penn team has developed a new class of malaria drugs by mimicking a natural reaction with a synthesized molecule, inhibiting the calpain enzyme. The innovation uses an alpha-helical shape to block the enzyme's activity, offering a highly specific and potentially safer alternative.
A team of researchers at the University of Pennsylvania School of Medicine has identified a powerful new weapon against malaria by mimicking a natural defense found in human blood platelets. They discovered that a synthetic molecule, PMX1207, targets and destroys the parasite's digestive vacuole, killing it without harming the host cell.
Researchers at the University of Pennsylvania developed a non-invasive MRI-based algorithm to screen patients for Alzheimer's disease or frontotemporal lobar degeneration. The method, published in Neurology, accurately differentiated cases 75 percent of the time and showed comparable accuracy to lumbar puncture tests.
Researchers found that enhanced aggressiveness of recurrent tumors is due to changes in immune response, specifically an increase in regulatory T cells and macrophages protecting tumor cells. Blocking these cells with new drugs could be a promising strategy for patients with recurrent disease.
Researchers identify protein kinase Akt as a regulator of cancer stem cell biology, linking its hyperactivation to cancer resistance. The findings suggest that targeting Akt could be a new approach for killing cancer stem cells in cancer therapy.
Researchers found that non-spouse caregivers are less likely to participate in Alzheimer's clinical trials, citing higher dropout rates and adverse events. The study highlights the need for tailored recruitment efforts to increase enrollment of patients with diverse caregiver arrangements.
A study published in Nature Neuroscience found that male rats exposed to cocaine showed resistance to its rewarding effects when given the drug as adults, while their female offspring did not. The researchers believe that this may be due to changes in gene expression triggered by paternal exposure to cocaine.
Researchers report success of gene transfer therapy to turn patients' immune cells into cancer-fighting weapons. Three patients remain in full remission over two years after treatment, marking first successful demonstration of the approach.
A recent study found that true aspirin resistance is extremely rare, with no cases identified. However, coated aspirin may lead to a false diagnosis due to delayed absorption and coating effects.
Researchers found that protected sleep periods increased time slept while on call by 50% and decreased overall time awake, leading to improved sleep quality and reduced fatigue. The study provides evidence that young doctors value the importance of sleep and are looking for ways to increase performance to better treat patients.
Residents in a new study by University of Pennsylvania researchers emphasize the negative impact of vacant land on physical and mental health. Participants expressed concerns about crime, stress, and feelings of helplessness when confronted with vacant lots, which often harbor garbage, vermin, and other hazards.
A study by researchers at the Perelman School of Medicine reveals how T-cell exhaustion occurs in chronic viral infections, with implications for novel therapies. The team found that two distinct classes of virus-specific CD8+ T cells work together to keep the infection in check, but their long-term pressure depletes progenitor pools.
A team of scientists from the University of Pennsylvania School of Medicine and Temple University discovered an essential mechanism that regulates calcium uptake into mitochondria, crucial for ATP synthesis. The newly described protein MCUR1 interacts with MCU to establish proper calcium levels under normal conditions.
Researchers have identified a key pathway called the Unfolded Protein Response (UPR) that helps tumor cells escape programmed cell death during lymphoma development. Inhibiting this pathway could lead to new blood cancer treatments.
Researchers discovered that yeast protein Hsp104 can break up both amyloid fibrils and disordered protein clumps, with different requirements for stability. This finding offers a new approach to eliminate toxic clumps linked with neurodegenerative diseases.